Seoul National University Children's Hospital
Seoul, 03080, South Korea
NCT Number: NCT06979167
The goal of this observational study is to understand the incidence and risk factors of complications associated with midline catheter placement in pediatric patients (under 18 years old) undergoing general anesthesia. The main questions it aims to answer are:
What is the overall complication rate (including malfunction, bleeding, thrombosis, inflammation, and infection) after midline catheter placement in children?
What factors (e.g., age, weight, vein diameter, insertion site, catheter maintenance duration) are associated with a higher risk of complications?
Participants will:
Receive a midline catheter during surgery under general anesthesia.
Undergo ultrasound-guided assessment of the catheter site immediately after placement, 24 hours later, and before the catheter is removed.
Be monitored for any complications related to the catheter, including infection, blood clots, or blockage.
This study will help identify which factors increase the risk of complications, improving the safe use of midline catheters in pediatric patients.
Looking for future studies?
Notify Me1 year–18 year
All sexes
Observational
Seoul, 03080, South Korea
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention involves the ultrasound-guided insertion of a midline catheter into a peripheral vein (basilic, cephalic, or brachial vein) during general anesthesia in pediatric patients.
Time frame: From midline catheter insertion to catheter removal (up to 7 days).
The overall complication rate is defined as the proportion of patients experiencing any catheter-related complications, including catheter malfunction, infection (clinical signs or positive culture), bleeding at the insertion site, thrombosis (confirmed by ultrasound), and catheter dislodgement.
Time frame: From midline catheter insertion to catheter removal (up to 7 days).
The incidence of each specific complication type will be recorded, including:
Catheter malfunction (clinical assessment), Infection (clinical signs or positive culture), Bleeding at the insertion site (visual inspection), Thrombosis (confirmed by ultrasound), Catheter dislodgement (clinical assessment)
Time frame: From midline catheter insertion to catheter removal (up to 7 days).
The total duration (in days) that each patient maintains a functional midline catheter without premature removal.
Time frame: From midline catheter insertion to catheter removal (up to 7 days).
The primary reason for catheter removal will be documented, including: Planned removal (completion of clinical need), Premature removal due to complications (infection, malfunction, thrombosis, or patient discomfort)
Time frame: From midline catheter insertion to catheter removal (up to 7 days)
The presence of thrombosis at the catheter site will be assessed using ultrasound. Ultrasound will be performed immediately after insertion, 24 hours later, and at the time of catheter removal. Thrombosis will be defined as the presence of an intraluminal thrombus or significant vein narrowing.
Time frame: From midline catheter insertion to catheter removal (up to 7 days)
This outcome measures the frequency and types of treatments administered for complications associated with the midline catheter, including:
Seoul National University Hospital
Other
Study on Complications After Midline Catheter Placement and the Risk Factors in Children
Acronym: MIDline
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04911842
Midline Catheter
Romeoville, Illinois, United States
View Trial DetailsNCT07654101
Bites and Stings, Chemically-Induced Disorders
View Trial DetailsNCT06904651
Midline Catheter, Orthopedic Surgery
Bologna, BO, Italy
View Trial DetailsNCT07555314
Chronic Pain, Lidocaine Infusion
Warsaw, Poland
View Trial Details